Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More.com Offers "Forever More" Fixed Price Introductory Promotion

This article was originally published in The Tan Sheet

Executive Summary

More.com is debuting with a "Forever More" promotional offer allowing new shoppers the opportunity to secure life-long prices on initial items purchased. The online source of health, beauty and wellness products opened for business the week of Aug. 16.

You may also be interested in...



More.com Retooling, Expansion Planned For Estimated IPO Proceeds

More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.

More.com Retooling, Expansion Planned For Estimated IPO Proceeds

More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.

More.com Retooling, Expansion Planned For Estimated IPO Proceeds

More.com's proposed maximum aggregate offering price is $86.3 mil. for its upcoming initial public offering, the online retailer says in a preliminary registration statement filed with the Securities & Exchange Commission Feb. 11. The price is estimated because the firm has not specified the number of shares or per-share price in the filing.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel